Foley Hoag LLP advised Pear Therapeutics, Inc. on the deal.Pear Therapeutics, Inc., a pioneer of prescription digital therapeutics (PDTs), announced the extension of its Series D financing,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
